If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
This report was created for strategic planners, international marketing executives and export managers whose primary concern is the world market for unmixed vitamins b and derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for unmixed vitamins b and derivatives for those firms serving the world via exports and foreign direct investment. It does so for the current year based on a variety of key historical indicators and econometric models.
In what follows, this report begins by summarizing the world market for unmixed vitamins b and derivatives exports. The total level of exports on a worldwide basis is based on a model that aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on supply-side dynamics, market shares by country of origin are then calculated across each country market. These shares lead to a volume of export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each supplier and the destinations (countries served by the supplier country). From these figures, world rankings are calculated. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
Table Of Contents:
1 METHODOLOGY & EXECUTIVE SUMMARY 71.1 Our Approach 71.2 The World Market: Unmixed Vitamins B and Derivatives Export Supplies in 2016 101.3 The World Market: Unmixed Vitamins B and Derivatives by Destination in 2016 132 AFRICA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES 152.1 Executive Summary 152.2 Egypt 172.3 South Africa 182.4 Swaziland 183 ASIA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES 193.1 Executive Summary 193.2 Burma 223.3 China 233.4 Hong Kong 243.5 India 253.6 Indonesia 263.7 Japan 273.8 Malaysia 283.9 Singapore 283.10 South Korea 293.11 Sri Lanka 303.12 Taiwan 303.13 Thailand 303.14 Vietnam 314 EUROPE: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES 324.1 Executive Summary 324.2 Austria 354.3 Belgium 364.4 Bulgaria 374.5 Cyprus 374.6 Czech Republic 374.7 Denmark 384.8 Finland 384.9 France 394.10 Germany 404.11 Greece 414.12 Hungary 414.13 Iceland 414.14 Ireland 414.15 Italy 424.16 Lithuania 424.17 Norway 434.18 Poland 434.19 Portugal 434.20 Russia 444.21 Slovakia 444.22 Spain 454.23 Sweden 464.24 the Netherlands 475 LATIN AMERICA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES 485.1 Executive Summary 485.2 Argentina 515.3 Brazil 525.4 Colombia 525.5 Guatemala 525.6 Mexico 535.7 Panama 536 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES 546.1 Executive Summary 546.2 Canada 576.3 Dominica 586.4 the United States 597 OCEANA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES 607.1 Executive Summary 607.2 Australia 618 THE MIDDLE EAST: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES 628.1 Executive Summary 628.2 Israel 648.3 Jordan 658.4 Turkey 659 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 669.1 Disclaimers & Safe Harbor 669.2 ICON Group International, Inc. User Agreement Provisions 67